Literature DB >> 28520591

Stem cell therapy and its potential role in pituitary disorders.

Montserrat Lara-Velazquez1, Oluwaseun O Akinduro, Ronald Reimer, Whitney W Woodmansee, Alfredo Quinones-Hinojosa.   

Abstract

PURPOSE OF REVIEW: The pituitary gland is one of the key components of the endocrine system. Congenital or acquired alterations can mediate destruction of cells in the gland leading to hormonal dysfunction. Even though pharmacological treatment for pituitary disorders is available, exogenous hormone replacement is neither curative nor sustainable. Thus, alternative therapies to optimize management and improve quality of life are desired. RECENT
FINDINGS: An alternative modality to re-establish pituitary function is to promote endocrine cell regeneration through stem cells that can be obtained from the pituitary parenchyma or pluripotent cells. Stem cell therapy has been successfully applied to a plethora of other disorders, and is a promising alternative to hormonal supplementation for resumption of normal hormone homeostasis.
SUMMARY: In this review, we describe the common causes for pituitary deficiencies and the advances in cellular therapy to restore the physiological pituitary function.

Entities:  

Mesh:

Year:  2017        PMID: 28520591     DOI: 10.1097/MED.0000000000000346

Source DB:  PubMed          Journal:  Curr Opin Endocrinol Diabetes Obes        ISSN: 1752-296X            Impact factor:   3.243


  2 in total

Review 1.  Advances in Brain Tumor Surgery for Glioblastoma in Adults.

Authors:  Montserrat Lara-Velazquez; Rawan Al-Kharboosh; Stephanie Jeanneret; Carla Vazquez-Ramos; Deependra Mahato; Daryoush Tavanaiepour; Gazanfar Rahmathulla; Alfredo Quinones-Hinojosa
Journal:  Brain Sci       Date:  2017-12-20

2.  Functional Restoration of Pituitary after Pituitary Allotransplantation into Hypophysectomized Rats.

Authors:  Jai Ho Choi; Jung Eun Lee; Hong-Lim Kim; Seung Hyun Ko; Se Hoon Kim; Seung Ho Yang
Journal:  Cells       Date:  2021-01-29       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.